查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1266698

細胞分解/細胞分離的全球市場:趨勢，機會，競爭分析

Cell Lysis & Fractionation Market: Trends, Opportunities and Competitive Analysis [2023-20
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球細胞分解/細胞分離的市場規模，預計從2023年至2028年以8.3％的年複合成長率成長，到2028年達到估計53億美元。促進市場成長的主要原因，是感染疾病數的劇增，基因學和蛋白質體學研究的政府資金增加，對個人化醫療的關注度高漲等。

本報告提供全球細胞分解/細胞分離市場調查，市場概要，市場規模和預測，趨勢，促進因素、課題，各產品、各細胞類型、各用途、各最終用途產業、各地區等的分析，再加上競爭分析等資訊。

目錄

第1章 摘要整理

第2章 全球細胞分解/細胞分離市場:市場動態

  • 簡介，背景，及分類
  • 供應鏈
  • 產業的推動因素與課題

第3章 市場趨勢與預測分析(2017年～2028年)

  • 宏觀經濟趨勢(2017年～2022年)與預測(2023年～2028年)
  • 全球細胞分解/細胞分離市場趨勢(2017年～2022年)與預測(2023年～2028年)
  • 全球細胞分解/細胞分離市場:各產品
    • 消耗品
      • 套件、試劑
    • 設備
      • 超音波振盪器
      • 均質機
      • 其他
  • 全球細胞分解/細胞分離市場:各細胞類型
    • 哺乳類細胞
    • 微生物細胞
    • 其他
  • 全球細胞分解/細胞分離市場:各用途
    • 蛋白質的精製、分離
    • 核酸的分離、精製
    • 其他
  • 全球細胞分解/細胞分離市場:各最終用途產業
    • 研究實驗室、機關
    • 生物醫藥品、生物科技企業
    • 其他

第4章 市場趨勢與預測分析:各地區(2017年～2028年)

  • 全球細胞分解/細胞分離市場，各地區
  • 北美的細胞分解/細胞分離市場
    • 北美的細胞分解/細胞分離市場，細胞各類型:哺乳類細胞，微生物細胞，其他
    • 北美的細胞分解/細胞分離市場，各最終用途產業:研究實驗室、機關，生物醫藥品、生物科技企業，其他
  • 歐洲的細胞分解/細胞分離市場
    • 歐洲的細胞分解/細胞分離市場，細胞各類型:哺乳類細胞，微生物細胞，其他
    • 歐洲的細胞分解/細胞分離市場，各最終用途產業:研究實驗室、機關，生物醫藥品、生物科技企業，其他
  • 亞太地區的細胞分解/細胞分離市場
    • 亞太地區的細胞分解/細胞分離市場，細胞各類型:哺乳類細胞，微生物細胞，其他
    • 亞太地區的細胞分解/細胞分離市場，各最終用途產業:研究實驗室、機關，生物醫藥品、生物科技企業，其他
  • 其他地區的細胞分解/細胞分離市場
    • 其他地區的細胞分解/細胞分離市場，細胞各類型:哺乳類細胞，微生物細胞，其他
    • 其他地區的細胞分解/細胞分離市場，各最終用途產業:研究實驗室、機關，生物醫藥品、生物科技企業，其他

第5章 競爭分析

  • 類型組合分析
  • 運用整合
  • 波特的五力分析

第6章 成長機會及策略分析

  • 成長機會分析
    • 全球細胞分解/細胞分離市場成長機會:各產品
    • 全球細胞分解/細胞分離市場成長機會:各細胞類型
    • 全球細胞分解/細胞分離市場成長機會:各用途
    • 全球細胞分解/細胞分離市場成長機會:各最終用途產業
    • 全球細胞分解/細胞分離市場成長機會:各地區
  • 全球細胞分解/細胞分離市場上新的趨勢
  • 策略分析
    • 新產品的開發
    • 全球細胞分解/細胞分離市場通訊容量擴大
    • 全球細胞分解/細胞分離市場的合併，收購，及合資企業
    • 檢定和授權

第7章 主要企業的企業簡介

  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Miltenyi Biotec
  • Becton Dickinson
簡介目錄

Cell Lysis & Fractionation Market Trends and Forecast

The future of the global cell lysis & fractionation market looks promising with opportunities in the research laboratories and institutes, and biopharmaceutical and biotechnology companies. The global cell lysis & fractionation market is expected to reach an estimated $5.3 billion by 2028 with a CAGR of 8.3% from 2023 to 2028. The major drivers for this market are a surge in the number of infectious diseases, growing government funding for research in genomics and proteomics, and increasing focus on personalized medicine.

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.

Cell Lysis & Fractionation Market by Segment

The study includes trends and forecast for the global cell lysis & fractionation market by product, cell type, application, end use industry, and region, as follows:

Cell Lysis & Fractionation Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Consumables
    • Kits and Reagents
  • Enzymes
  • Detergent Solutions
  • Others
  • Instruments
    • Sonicators
    • Homogenizers
    • Other Instruments

Cell Lysis & Fractionation Market by Cell Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Mammalian Cells
  • Microbial Cells
  • Others

Cell Lysis & Fractionation Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Protein Purification and Isolation
  • Nucleic Acid Isolation and Purification
  • Others

Cell Lysis & Fractionation Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Research Laboratories and Institutes
  • Biopharmaceutical and Biotechnology Companies
  • Others

Cell Lysis & Fractionation Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cell Lysis & Fractionation Companies

Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, cell lysis & fractionation companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the cell lysis & fractionation companies profiled in this report include-

  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Miltenyi Biotec
  • Becton Dickinson

Cell Lysis & Fractionation Market Insights

  • Lucintel forecasts that mammalian cells are expected to remain the larger type segment over the forecast period due to increasing investments by governments and private companies in cell-based research activities.
  • Research laboratories and institutes are expected to witness the highest growth over the forecast period due to increasing incidence of chronic disease and rising government investment for research.
  • North America is expected to remain the largest region over the forecast period due to rapidly growing biotechnology & pharmaceutical industries and increasing stem cell and cancer research activities.

Features of the Cell Lysis & Fractionation Market

  • Market Size Estimates: Cell lysis & fractionation market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Cell lysis & fractionation market size by various segments, such as product, cell type, application, end use industry, and region
  • Regional Analysis: Cell lysis & fractionation market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different types, product, cell type, application, end use industry, and regions for the cell lysis & fractionation market.
  • Strategic Analysis: This includes M&A, new type development, and competitive landscape for the cell lysis & fractionation market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the cell lysis & fractionation market size?

Answer: The global cell lysis & fractionation market is expected to reach an estimated $5.3 billion by 2028.

Q2. What is the growth forecast for cell lysis & fractionation market?

Answer: The global cell lysis & fractionation market is expected to grow with a CAGR of 8.3% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the cell lysis & fractionation market?

Answer:The major drivers for this market are a surge in the number of infectious diseases, growing government funding for research in genomics and proteomics, and increasing focus on personalized medicine.

Q4. What are the major segments for cell lysis & fractionation market?

Answer: The future of the cell lysis & fractionation market looks promising with opportunities in the research laboratories and institutes, and biopharmaceutical and biotechnology companies.

Q5. Who are the key cell lysis & fractionation companies?

Answer: Some of the key cell lysis & fractionation companies are as follows:

  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Miltenyi Biotec
  • Becton Dickinson

Q6. Which cell lysis & fractionation segment will be the largest in future?

Answer:Lucintel forecasts that mammalian cells are expected to remain the larger type segment over the forecast period due to increasing investments by governments and private companies in cell-based research activities.

Q7. In cell lysis & fractionation market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to remain the largest region over the forecast period due to rapidly growing biotechnology & pharmaceutical industries and increasing stem cell and cancer research activities.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1. What are some of the most promising, high-growth opportunities for the global cell lysis & fractionation market by product ((consumables( kits and reagents (enzymes, detergent solutions, and others)), instruments (sonicators, homogenizers, and other instruments)), cell type (mammalian cells, microbial cells, and other cells), application (protein purification and isolation, nucleic acid isolation and purification, and others), end use industry (research laboratories and institutes, biopharmaceutical and biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cell lysis & fractionation Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Cell Lysis & Fractionation Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Cell Lysis & Fractionation Market by Product
    • 3.3.1: Consumables
      • 3.3.1.1: Kits and Reagents
        • 3.3.1.1.1: Enzymes
        • 3.3.1.1.2: Detergent Solutions
        • 3.3.1.1.3: Others
    • 3.3.2: Instruments
      • 3.3.2.1: Sonicators
      • 3.3.2.2: Homogenizers
      • 3.3.2.3.: Other Instruments
  • 3.4: Global Cell Lysis & Fractionation Market by Cell Type
    • 3.4.1: Mammalian Cells
    • 3.4.2: Microbial Cells
    • 3.4.3: Others
  • 3.5: Global Cell Lysis & Fractionation Market by Application
    • 3.5.1: Protein Purification and Isolation
    • 3.5.2: Nucleic Acid Isolation and Purification
    • 3.5.3: Others
  • 3.6: Global Cell Lysis & Fractionation Market by End Use Industry
    • 3.6.1: Research Laboratories and Institutes
    • 3.6.2: Biopharmaceutical and Biotechnology Companies
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Cell Lysis & Fractionation Market by Region
  • 4.2: North American Cell Lysis & Fractionation Market
    • 4.2.1: North American Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
    • 4.2.2: North American Cell Lysis & Fractionation Market by End Use Industry : Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
  • 4.3: European Cell Lysis & Fractionation Market
    • 4.3.1: European Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
    • 4.3.2: European Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
  • 4.4: APAC Cell Lysis & Fractionation Market
    • 4.4.1: APAC Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
    • 4.4.2: APAC Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
  • 4.5: ROW Cell Lysis & Fractionation Market
    • 4.5.1: ROW Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
    • 4.5.2: ROW Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others

5. Competitor Analysis

  • 5.1: Type Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Product
    • 6.1.2: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Cell Type
    • 6.1.3: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Application
    • 6.1.4: Growth Opportunities for the Global Cell Lysis & Fractionation Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Region
  • 6.2: Emerging Trends in the Global Cell Lysis & Fractionation Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cell Lysis & Fractionation Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cell Lysis & Fractionation Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Merck KGaA
  • 7.3: Bio-Rad Laboratories
  • 7.4: Miltenyi Biotec
  • 7.5: Becton Dickinson